FindTrial
Sign In

Assessment of ventricle fibrosis in atrial fibrillation by quantitative magnetic resonance imaging and its role in predicting success of catheter ablation

Assessment of ventricle fibrosis in atrial fibrillation by quantitative magnetic resonance imaging and its role in predicting success of catheter ablation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016598
Enrollment
Unknown
Registered
2018-06-11
Start date
2016-02-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

AF patients:catheter ablation
healthy volunteers:n.a

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 81 Years

Inclusion criteria

Inclusion criteria: Included criterion: aged=18 years,In the past 6 months, the onset of atrial fibrillation (>30s) were record by electrocardiogram (ECG) or dynamic electrocardiogram (ECG). Patients will receive catheter ablation, sign the informed consent form and agree to follow up.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with contraindications for MRI examination; patients who had undergone percutaneous catheter ablation or surgical ablation for atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
AF recurrence;—

Secondary

MeasureTime frame
MACCE;—

Countries

China

Contacts

Public ContactMa Xiaohai

Beijing Anzhen Hospital, Capital Medical University

maxi8238@yahoo.com+86 13661288427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026